Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma

Inna Chen*, Victoria M. Raymond, Jennifer A. Geis, Eric A. Collisson, Benny V. Jensen, Kirstine L. Hermann, Mark G. Erlander, Margaret Tempero, Julia S. Johansen

*Corresponding author for this work
12 Citations (Scopus)
57 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences